Outcomes in a Comparison of Manual Penetrating Keratoplasty and the IntraLase® Enabled Keratoplasty
NCT ID: NCT00566605
Last Updated: 2007-12-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1
60 participants
INTERVENTIONAL
2007-08-31
2008-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Penetrating keratoplasty with IntraLase
penetrating keratoplasty with femtosecond laser shaped incisions- IntraLase TM (IntraLase Enabled Keratoplasty \[IEK\])
Group 2
Penetrating keratoplasty with vacuum trephine
Group 2 - penetrating keratoplasty with vacuum trephine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Penetrating keratoplasty with IntraLase
penetrating keratoplasty with femtosecond laser shaped incisions- IntraLase TM (IntraLase Enabled Keratoplasty \[IEK\])
Penetrating keratoplasty with vacuum trephine
Group 2 - penetrating keratoplasty with vacuum trephine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Oftalmologico de Sorocaba
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
HOSBOS
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elissandro M Silva, Lindoso
Role: PRINCIPAL_INVESTIGATOR
Hospital Oftalmologico de Sorocaba
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sorocaba Eye Bank - HOSBOS
Sorocaba, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
466.07
Identifier Type: -
Identifier Source: org_study_id